spacer
The Healthcare Sales & Marketing Network celebrates 23 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  XenoPort 

 HSMN NewsFeed - 24 Jul 2018
Soligenix Announces Appointment of Mark Pearson to its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Feb 2017
AcelRx Pharmaceuticals Appoints Vincent J. Angotti Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 Apr 2016
Symic Appoints Kathleen Gogas, Ph.D., as VP of Preclinical Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 Aug 2015
Radius Health Announced That it Has Appointed Catherine Friedman to the Board of Directors
Biopharmaceuticals Endocrinology Personnel
 HSMN NewsFeed - 22 May 2014
Third Rock Ventures and The Column Group Launch Nurix with $25.1 Million Financing to Target Key Regulatory Pathway
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 27 Mar 2014
Nora Therapeutics Expands Board of Directors with Appointment of Dennis M. Fenton
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Jan 2014
XenoPort Appoints Richard Kim, M.D., as Chief Medical Officer
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 13 Nov 2013
Novelos Therapeutics Announces a Restructuring of Its Board of Directors and Additional Changes to Its Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Sep 2013
Jeryl L. Hilleman Joins Ocera Therapeutics as Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 Jul 2013
XenoPort Announces Inclusion of Horizant (Gabapentin Enacarbil) in Guidelines for Long-Term Treatment of Restless Legs Syndrome/Willis-Ekbom Disease
Biopharmaceuticals Neurology
 HSMN NewsFeed - 31 Jul 2012
Hospira Expands Board of Directors With Election of Dennis M. Fenton
Devices Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 Jun 2012
XenoPort Appoints Ernest Mario, Ph.D., to Board of Directors
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 7 Jun 2012
GSK and XenoPort Receive FDA Approval for Horizant(R) for Postherpetic Neuralgia
Biopharmaceuticals FDA
 HSMN NewsFeed - 18 Jan 2012
Astellas and XenoPort Announce Approval of Regnite(R) Tablets for Restless Legs Syndrome in Japan
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 4 Apr 2011
Anacor Pharmaceuticals Appoints William J. Rieflin to Its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Feb 2011
Cytokinetics Announces Changes to Its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 Jan 2011
Genelux Corporation Expands Board of Directors, Appointing Dennis Fenton, Former Amgen Executive
Biopharmaceuticals Diagnostics Personnel
 HSMN NewsFeed - 5 Oct 2010
NGM Biopharmaceuticals Names William J. Rieflin Chief Executive Officer and Director
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 Aug 2010
Euthymics Bioscience, Inc. Appoints Industry Veterans Dr. Pierre Trān, Joan Manthis and William Pappafotopoulos to Senior Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Mar 2010
XenoPort Restructures to Focus on Key Programs
Biopharmaceuticals
 HSMN NewsFeed - 13 Aug 2009
XenoPort Appoints Dennis Fenton to Board
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Apr 2009
XenoPort Announces Election of Co-Promotion Option for Solzira
Biopharmaceuticals
 HSMN NewsFeed - 9 Jan 2009
GSK and XenoPort Resubmit New Drug Application for Solzira(TM) in Restless Legs Syndrome
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 16 Sep 2008
GSK and XenoPort Announce Submission of New Drug Application Requesting FDA Approval of Solzira(TM) for Restless Legs Syndrome
Biopharmaceuticals
 HSMN NewsFeed - 5 Aug 2008
Xanodyne Achieves Positive Efficacy Results in Pivotal Phase 3 Studies of Proprietary Modified Release Oral Tranexamic Acid Product Candidate for Heavy Menstrual Bleeding
Biopharmaceuticals
 HSMN NewsFeed - 15 Jul 2008
XenoPort Appoints David A. Stamler, M.D., as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 Jul 2008
Agios Pharmaceuticals Closes $33 Million Series A Funding
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 1 May 2008
XenoPort Appoints Vincent J. Angotti as Chief Commercialization Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 28 Feb 2008
XenoPort and GlaxoSmithKline Report Positive Top-Line Results of Final Pivotal Trial of XP13512/GSK1838262 for Restless Legs Syndrome
Biopharmaceuticals
 HSMN NewsFeed - 27 Nov 2007
BIND Biosciences, Inc. Closes $16M Series B Financing Round
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 26 Oct 2007
Allozyne, Inc., Closes $30 Million Series B Financing and Appoints Meenu Chhabra as President and Chief Executive Officer
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 16 Oct 2007
Cortex Names Pierre V. Tran, MD, MMM, Chief Medical Officer and Vice President of Clinical Development
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 25 Apr 2007
XenoPort Reports Positive Top-Line Phase 3 Trial Results of XP13512 in Restless Legs Syndrome
Biopharmaceuticals
 HSMN NewsFeed - 21 Feb 2007
ARYx Therapeutics Appoints New Chief Development Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Feb 2007
GlaxoSmithKline and XenoPort Announce Agreement on Late-Stage Compound for RLS and Neuropathic Pain
Biopharmaceuticals
 HSMN NewsFeed - 8 Jan 2007
Ambit Biosciences Appoints Wendell Wierenga, Ph.D., as Executive Vice President of Research & Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 Oct 2006
XenoPort Announces Positive Results From XP19986 Phase 2a Trial in Patients with Gastroesophageal Reflux Disease
Biopharmaceuticals Gastroenterology
 HSMN NewsFeed - 4 Oct 2006
OREXIGEN(TM) Therapeutics Expands Senior Management Team as Lead Products Advance Through Late-Stage Clinical Trials
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Mar 2006
XenoPort Initiates Phase 3 Clinical Program for XP13512 as a Treatment for Restless Legs Syndrome
Biopharmaceuticals
Return to NewsFeed  

 Additional items found! 11

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 11 additional stories matching:
XenoPort
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.